(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

KESMALEA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

KESMALEA

ST13

US500000098555977

Classe

1, 5, 9, 10, 42, 44

Pedido

98555977

Registro

7863616

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

21

Atualização mais recente

15/07/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 10, 42, 44

Data de depósito

17/05/2024

Data de registro

15/07/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

15/07/2025

Última transação

15/07/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

24

Localização do titular

London, GB

Examinador

FOSS, KATHERINE M

Unidade examinadora

L80

Localização atual

TMEG LAW OFFICE 108

Titulares e representantes

Titulares

Kesmalea Therapeutics Limited

Representantes

Stacy J. Grossman Law Office of Stacy J. Grossman PLLC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 10Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Proteins for use in science; regulatory proteins for scientific and medical use; chemical reagents for use in biotechnology scienceother than for medical or veterinary use

Classe 5

Pharmaceutical preparations for oncologyimmunologyviral infectionscentral nervous diseases; pharmaceutical preparationsin particularchemical and biological preparations for medical purposes; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria; biological preparations for the treatment of cancer; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for the treatment of central nervous system diseases; biological preparations for medical use for the treatment of cancerautoimmune diseasesviral infectionscentral nervous diseases; immunotherapeutic drugs; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; protein synthesis inhibitors in the nature of antibioticsnone of the foregoing relating to preparations for the treatment of central nervous system diseases and disorders

Classe 9

Scientific apparatus being spectrometers and parts and fittings thereforresearch apparatus being nuclear medical research imaging apparatusnavigation apparatus being on-board computers for vehiclessurveying apparatusphotographic apparatus being camerascinematographic camerasaudiovisual receiversoptical readersweighing machineslaser measuring systemssignalling whistlesradiation detecting apparatusplastic testing machinescameras for monitoring and inspecting equipmentlife-saving raftsteaching apparatus and instrumentsartificial limbs for medical instruction purposes; recorded computer operating software; recorded computer operating software for use in scientific and pharmaceutical research and development; recorded computer software for scientific modelling; recorded computer software for pharmaceutical modelling; recorded computer software for conducting research and development in the field of oncologyimmunology and central nervous system disease; recorded computer software for the managinganalysisvisualisation of biological data; devices for analysing protein sequence used as laboratory apparatuslaboratory devices for detecting genetic sequences

Classe 10

Surgical apparatus and instruments and medical imaging apparatus; medical devices for treatment of cancerautoimmune diseasesviral infections and central nervous diseases; apparatus for drug administrationdisposable syringes; medical diagnostic apparatus for the detection of abnormal prion protein

Classe 42

Scientific laboratory servicesmedical research laboratory servicestechnological servicesresearch and design in the field of targeted protein degradation; research relating to molecular sciences; blood analysis in the field of molecular biology for scientific research purposes; drug discovery services; clinical surgery research; medical research; biological research; medical research relating to pharmaceuticals; pharmaceutical research and development; development of pharmaceutical preparations and medicines; platform as a service (PaaS) featuring computer software platforms for data analysis; platform as a service (PaaS) featuring software platforms for medical analysis software; software as a service (Saas) featuring software for patient information and databases; software as a service (Saas) featuring medical analysis software; provision of temporary use of onlinenon-downloadable software for the managementvisualisation and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; biotechnology research; biotechnology testing for medical research purposes; research and development in the pharmaceutical and biotechnology fields; scientific screening and assayingtestinganalysisevaluation of clinical data; chemical analysis; chemical research; medical research in the field of oncologyimmunology and central nervous system diseases; research and development in the field of protein homeostasis; scientific research in the nature of conducting clinical trials for others

Classe 44

Medical services; medical analysis services relating to the treatment of persons; oral medical care services; medical diagnostic services; diagnostic and prognostic medical services; advisory services relating to medical services; medical screening; medical services in the field of oncology and immunotherapy; pharmacy adviceprescription refill reminder services; medical and health clinic services relating to antibodiesimmuno-oncologyinflammationhaematologycentral nervous system and infectious disease

Publicações

Histórico de despachos e eventos da marca no USPTO.

21 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

15/07/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

15/07/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

27/05/2025

PUBO

PUBLISHED FOR OPPOSITION

27/05/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

21/05/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

29/04/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

23/04/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

23/04/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

23/04/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

23/04/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/02/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/02/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/02/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/12/2024

GNRT

NON-FINAL ACTION E-MAILED

04/12/2024

CNRT

NON-FINAL ACTION WRITTEN

04/12/2024

DOCK

ASSIGNED TO EXAMINER

03/12/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

20/11/2024

TAEA

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

18/10/2024

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

18/10/2024

NWAP

NEW APPLICATION ENTERED

17/05/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace KESMALEA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.